Smurf2 suppresses B-cell proliferation and lymphomagenesis by mediating ubiquitination and degradation of YY1

About half of patients with diffuse large B-cell lymphoma (DLBCL) do not respond to or relapse soon after the standard chemotherapy, indicating a critical need to better understand the specific pathways perturbed in DLBCL for developing effective therapeutic approaches. Mice deficient in the E3 ubiq...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramkumar, Charusheila, Cui, Hang, Kong, Yahui, Jones, Stephen N., Gerstein, Rachel M., Zhang, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2013
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3801104/
https://www.ncbi.nlm.nih.gov/pubmed/24121673
http://dx.doi.org/10.1038/ncomms3598

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3801104/
https://www.ncbi.nlm.nih.gov/pubmed/24121673
http://dx.doi.org/10.1038/ncomms3598

Ejemplares similares